Microbes without plasmids divide faster than those harbouring them. Microbiolo-6 gists rely on this difference in growth rate between both types to foresee whether 7 a plasmid will be maintained, or else purged by the host to avoid extinction. Here 8 I report that plasmids change multiple life-history traits, and I demonstrate that 9 growth rate alone can be a bad predictor for plasmid maintenance. Pairwise com-10 petition experiments between two constructs of Escherichia coli-one of which car-11 ries a plasmid-revealed that harbouring plasmids can also increase yield and delay 12 growth (lag). Crucially, yield engaged in a trade-off with growth rate. The plasmid 13 borne by one construct (R), non-transmissible and with a tetracycline-resistance 14 gene, reduced its host's growth rate by 20%. However, given this trade-off, R 15 outgrew its sensitive counterpart (S) in the absence of tetracycline when the com-16 petition favoured yield over growth rate. Trade-offs like this can challenge the 17 application of concepts that depend on carriage costs: R-mutants with additional 18 copies of the plasmid exploited this trade-off, and were selected for in tetracycline 19
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trading-off ( Figure S3 ); so I asked whether the number of plasmids borne by R cells changed 159 through time with different tetracycline concentrations. It did. 160 To quantify the relative abundance of pGW155B within R cells, I sampled the mixed cultures 161 on days one and five, calculated the proportion of chromosomal DNA corresponding to the 162 construct R, and used quantitative polymerase chain reaction (qPRC) to measure the number of 163 plasmids borne per cell (see Methods). The initial pool of cells from this strain, grown overnight 164 and used to inoculate the cultures, contained 30.21 ± 6.72 copies of pGW155B per cell (mean 165 ± 95% confidence, n = 3). Without tetracycline, this number did not change significantly after 166 one and five days of competition against S (Mann-Whitney U-test p = 0.1, ranksum = 15, 167 Figure 3D ). But the relative abundance of pGW155B changed rapidly with increasing drug 168 concentrations. Within 24h the gain in plasmids was 2-fold, increasing 6-to 10-fold after five 169 days of competition depending on tetracycline concentration ( Figures 3E and F) . 170 To understand the relationship between plasmid copy number and drug concentration I Figure 3F , t-statistic = 2.4446, p = 0.0229, and 184 95% confidence interval (174.5, 1585.9)). The predictive power declined for the logistic model, 185 albeit it was still better than that for the linear model (adjusted R 2 = 0.394 versus 0.261).
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Discussion
187
Studies that look beyond the effect of plasmids on growth rate are extremely rare 12,13 . Growth 188 rate is associated with 'fitness' in microbes 5,8,30 and, therefore, it is used to measure the costs of 189 plasmid carriage 7,32,33 . My study suggests, however, that plasmids alter more than just growth 190 rate. This expands the number of traits that selection can act upon, in principle, regardless 191 of the genes borne by plasmids and the trade-off between growth rate and yield that I report, 192 mediated by the acquisition of pGW155B, is an example of this. Now, this begs the question 193 of whether growth rate is a reliable predictor of plasmid maintenance or, more generally, the 194 outcome of pairwise competitions. In my study it was not, given the trade-off between growth rate and yield, and that I favoured yield over growth rate to maintain pGW155B in R-cells 196 without using tetracycline. This shows that 'costs' of plasmid carriage, or indeed, antimicrobial 197 resistance are relative. However, I do not wish to overstate my results. Plasmids are incredibly 198 diverse in terms of size, genes, or transfer mechanism 34 , so the trade-off may be absent in other 199 types of plasmid. Nevertheless, this highlights that plasmids are not molecular parasites 5,35 200 necessarily and may provide their hosts with more benefits than previously thought.
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The relativity of 'costs', and importantly the relativity of drug sensitivity, poses serious 202 challenges to rationales, like the 'mutant selection window', that rely on plasmids or resistance with some dividing at faster rates than others 36-38 , so, it seems reasonable, drug sensitivity based 207 on growth rate data could be more informative of the microbe's sensitivity than sensitivity based 208 on cell density data. But the relativity of costs and sensitivity can also have its drawbacks. For 209 example, some traits may report a minimal selective concentration whereas other may not. The 210 mutant selection window hypothesis claims that drug concentrations below the minimal selective 211 concentration do not select for resistance 6,8,26 , however, antimicrobial-resistance genes (ARG) 212 are increasingly detected in environments with residual drug concentrations 39 . The relationship 213 between traits-here growth rate and yield-will determine whether such 'safety' net exists or 214 not.
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The changes in plasmid copy number that I found were unexpected, given the low tetracycline 216 concentrations used, suggesting that plasmids can be highly sensitive to selection. Plasmid DNA 217 can be substantially higher than chromosomal DNA in bacteria 40 , and its relative abundance can 218 change within the body during infections 41 . It is therefore surprising that international AMR 219 surveillance programmes 42 track only whether pathogens harbour plasmids, overlooking their 220 relative abundance within the cell. This has practical implications. For example, the curation 221 of plasmids from bacteria in vivo is gaining momentum as an alternative to treat drug-resistant 222 infections 43-46 . But the technique is still inefficient. It should be self-evident that pathogens 223 carrying fewer plasmids will be easier to treat than those bearing more copies of them, but the 224 variations in the number of plasmids borne are often overlooked. Equally, microbes hosting 225 more plasmids with antimicrobial-resistance genes should be less sensitive to antibiotics than 226 those harbouring fewer plasmids-despite harbouring exactly the same plasmid. Reporting this 227 information will be an asset in our fight against antimicrobial-resistant microbes. of 70 o C. The amplicon ranges between 100 to 141bp depending on the locus (Table S1 ). Two 
where cn is the number of plasmid copies per chromosome, S c and S p are the size of the chro- Figure S1 . Dose-response profile for tetracycline using culture density and lag data. Doseresponse profiles for each strain showing the change in culture density (A) and lag (B) with increasing tetracycline concentrations. The difference in R growth with respect to S was positive in antibiotic-free conditions (mean ± 95% confidence). Consequently, I could not detect any tetracycline concentration at which the profiles crossed over-minimal selective concentration-and establish the selection window for S. I estimated culture density from fluorescence data normalised with respect to optical density data (see Methods). In lag data, the difference between both types without tetracycline was negative and, thus, I could detect two MSCs at 0,082 ± 0.025 and .0.154 ± 0.021 µg/mL of tetracycline. Figure S2 . Sensitive type not fully outcompeted during the competition. A) Raw data for the construct S (black) and R (cyan) growing in M9 media supplemented with increasing tetracycline concentrations (different columns show different conditions). First and third rows show optical density data measured at 600nm, whereas second and fourth rows show density data estimated from relative fluorescence. B) Augmented detail of the evolved dose-response profiles of the tetracycline sensitive type S after seven days of exposure to tetracycline. Density data measured every 20min for seven 24h seasons (black) with the best fit to data (see main text) used to calculate growth parameters shown in grey. Each column represents the data set for one 24h season and each row the data set for one tetracycline concentration. Figure S6 . Raw data and model fit for resistant R strain. Raw optical Density data for GB(c) measured every 20min for seven 24h seasons (blue). The best fit to data (see Methods in main text) used to calculate bacterial fitness is shown in grey. Each column represents the data set for one 24h season and each row the data set for one tetracycline concentration. Figure S7 . Raw data and model fit for sensitive S strain. Raw optical Density data for Wyl measured every 20min for seven 24h seasons (black). The best fit to data (see Methods in main text) used to calculate bacterial fitness is shown in grey. Each column represents the data set for one 24h season and each row the data set for one tetracycline concentration. Figure S8 . Quantitative PCR calibration curves for tet(36) and tatB. Reaction efficiency for the set of primers and probes listed in the 'methods' section for tet(36) (A) and tatB. The efficiency was calculated as E f = 10 −1/Slope − 1, and the slope term calculated by fitting a linear model to qPCR threshold cycle (C t ) data. The mean ± standard deviation for the coefficient of determination R 2 and efficiency are shown in the figures. The amplification curves for each reaction are shown in C) and D), respectively.
